TALPHERA, INC. Contract Liability (Deferred Revenue)
TALPHERA, INC. (TLPH) had Contract Liability (Deferred Revenue) of $0 as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2021-05-17
- 2021-03-31: Contract with Customer, Liability, Current $0.00.
- 2020-12-31: Contract with Customer, Liability, Current $49.00K.
- 2020-09-30: Contract with Customer, Liability, Current $196.00K.
- 2020-06-30: Contract with Customer, Liability, Current $343.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 |
| 2020-12-31 | $49.00K 10-Q · filed 2021-05-17 |
| 2020-09-30 | $196.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $343.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $411.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $411.00K 10-K · filed 2021-03-15 |
| 2019-09-30 | $315.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $324.00K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $437.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $315.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |